Protara Therapeutics Inc (NAS:TARA)
$ 3.925 -0.11 (-2.73%) Market Cap: 220.60 Mil Enterprise Value: 87.87 Mil PE Ratio: 0 PB Ratio: 1.19 GF Score: 32/100

Protara Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 07:30 PM GMT
Release Date Price: $6.15 (+3.02%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TARA.OQ - Protara Therapeutics Inc
Protara Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 07:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thanks so much for joining our forty-sixth annual Healthcare conference. I'm Stacy Ku, part of the biotech team with my colleague Vish Shah. So, we'd love to welcome the Portara team, Jessie Shefferman, CEO, Jackie Zuma, co-founder and Chief Scientific Officer, Patrick Fabio, CFO, and Justin O'Malley, head of IR.

Thank you so much for joining. There's just so much investor interest these days and in MIBC and we're very excited to be discussing TA 022002. Recent and upcoming updates.

So just as a quick introduction, can you provide some background, on your lead program, Tara 002, and when I say brief, we'll probably dig into a lot of the recent data, so you're playing with fire step by step.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot